
Washington, D.C., September 15, 2026 (PAHO) – The Pan American Health Organization (PAHO) today announced a new pathway to access lenacapavir for HIV prevention in Latin America and the Caribbean through its Regional Revolving Funds, under an agreement with Gilead Sciences. The initiative will make the long-acting HIV prevention medicine available to 14 countries, complementing
read more








